These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 805019)

  • 1. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 4. Office management of hypertension.
    Moser M
    Am Fam Physician; 1974 Sep; 10(3):152-8. PubMed ID: 4414894
    [No Abstract]   [Full Text] [Related]  

  • 5. The reversibility of side effects of guanethidine therapy.
    Bauer GE; Hull RD; Stokes GS; Raftos J
    Med J Aust; 1973 May; 1(19):930-3. PubMed ID: 4736691
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate hypertension: treatment with guanethidine and methyldopa.
    Dunn MI; Freeman J
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):285-94. PubMed ID: 809241
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of guanethidine and hydrochlorothiazide in the long-term treatment of essential hypertension.
    Brown WJ; Brown FK
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):544-54. PubMed ID: 808377
    [No Abstract]   [Full Text] [Related]  

  • 9. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technique of controlled drug assay. IV. Comparison of guanethidine, methylopa, and a placebo in the hypertensive nergo woman.
    Levine PR; Rosenbloom SE; Shapera RP; Shapiro AP
    Arch Intern Med; 1968 Oct; 122(4):305-10. PubMed ID: 5676415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of essential arterial hypertension. V].
    Fossati C
    Clin Ter; 1980 Jun; 93(5):577-94. PubMed ID: 6107196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems of essential hypertension].
    Latotzki H
    Z Arztl Fortbild (Jena); 1965 Nov; 59(22):1196-9. PubMed ID: 5888328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of twice-daily dosage of methyldopa in essential hypertension.
    Hollifield JW; Slaton PE
    J Tenn Med Assoc; 1978 May; 71(5):337-40. PubMed ID: 661299
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 20. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.